Another Alzheimer’s blood test gets OK from FDA

By Sandee LaMotte – CNN Health

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help ​identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline.

The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are ​likely or unlikely to have Alzheimer’s-related brain changes, ​Roche said Monday.

The FDA clearance follows European ⁠approval for the test in May.